4.7 Review

Anogenital Distance or Digit Length Ratio as Measures of Fetal Androgen Exposure: Relationship to Male Reproductive Development and Its Disorders

Journal

JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM
Volume 98, Issue 6, Pages 2230-2238

Publisher

ENDOCRINE SOC
DOI: 10.1210/jc.2012-4057

Keywords

-

Funding

  1. UK Medical Research Council [G1100358]
  2. Medical Research Council [G1100358, G1002033] Funding Source: researchfish
  3. MRC [G1100358, G1002033] Funding Source: UKRI

Ask authors/readers for more resources

Context: Male reproductive disorders evident at birth or in young adulthood are remarkably common. They are hypothesized to comprise a testicular dysgenesis syndrome (TDS), with a fetal origin involving mild androgen deficiency. Evidence Acquisition: Testing this hypothesis requires seeing back in time.Two ways have been proposed: measurement of anogenital distance (AGD), or measurement of the 2:4 digit length ratio. This review assesses the evidence that they reflect fetalandrogenexposureandmightbeused to provide insight into the origin of TDS disorders. Evidence Synthesis: Supporting evidence for AGD derives from rat experimental studies that identified a fetal masculinization programming window, within which androgen action determines adult reproductive organ size, TDS disorders, and AGD. In humans, AGD is positively correlated to testis size, sperm count/fertility, penis length, and T levels, consistent with rat experimental data. The 2:4 digit ratio also shows associations with these parameters, but inconsistently between studies; evidence that the 2:4 digit ratio accurately reflects fetal androgen exposure is also equivocal. Conclusions: AGD appears to provide a reliable guide to fetal androgen exposure, although available data are limited. The next steps are to: standardize AGD measurement; obtain age-specific population data; and use AGD to evaluate the importance of fetal androgens in determining reproductive disorders and variation in testis/penis size and sperm count in the normal population. These studies should identify what, if any, clinical applications ofAGDmeasurement are feasiblefor example, its ability to predict adult-onset reproductive functionanddisorders.

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.7
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

No Data Available
No Data Available